Home
About
Overview
Sharing Data
ORCID
Help
History (57)
Sarcoma, Yoshida
2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, and The Society of Thoracic Surgeons.
Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
Receptors, Serotonin, 5-HT3
Development of mavoglurant and its potential for the treatment of fragile X syndrome.
See All 57 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of mavoglurant and its potential for the treatment of fragile X syndrome.
Development of mavoglurant and its potential for the treatment of fragile X syndrome. Expert Opin Investig Drugs. 2014 Jan; 23(1):125-34.
View in:
PubMed
subject areas
Animals
Fragile X Syndrome
Humans
Indoles
Receptor, Metabotropic Glutamate 5
authors with profiles
Elizabeth M Berry-Kravis